Next Article in Journal
Action of Chitosan Against Xanthomonas Pathogenic Bacteria Isolated from Euphorbia pulcherrima
Next Article in Special Issue
Ring-Expansion Reaction of Oximes with Aluminum Reductants
Previous Article in Journal
In Vitro, in Situ and in Vivo Studies on the Anticandidal Activity of Cassia fistula Seed Extract
Previous Article in Special Issue
Scope and Limitations of a Novel Synthesis of 3-Arylazonicotinates
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 17
Issue 6
10.3390/molecules17067010
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

5-(5-Aryl-1,3,4-oxadiazole-2-carbonyl)furan-3-carboxylate and New Cyclic C-Glycoside Analogues from Carbohydrate Precursors with MAO-B, Antimicrobial and Antifungal Activities

by
Mohamed Mohamed El-Sadek
1,*,
Seham Yassen Hassan
1,
Nagwa Said Abd El-Dayem
1 and
Galila Ahmed Yacout
2
1
Chemistry Department, Faculty of Science, Alexandria University, Alexandria 21231, Egypt
2
Biochemistry Department, Faculty of Science, Alexandria University, Alexandria 21231, Egypt
*
Author to whom correspondence should be addressed.
Molecules 2012, 17(6), 7010-7027; https://doi.org/10.3390/molecules17067010
Submission received: 1 April 2012 / Revised: 27 April 2012 / Accepted: 9 May 2012 / Published: 7 June 2012
(This article belongs to the Special Issue Heterocycles)
Browse Figures
Versions Notes

Abstract

:
Cyclization of acyclic C-glycoside derivatives 1a,b to 2a,b as the major isomers, and 4a,b as the minor isomers were carried out. The isopropylidene derivatives 3a,b were prepared, as well as the hydrazide derivative 6, which was condensed with a variety of aldehydes to give hydrazones 7a–e which were also prepared from the compounds 12a–e. Acetylation of 7a,d gave the corresponding acetyl derivatives 8a,d, respectively. In addition, the dicarbonyl compound 9 was prepared in the hydrate form, which reacted with a number of aroylhydrazines to give the corresponding bisaroyl-hydrazones 10a–d, which were cyclized into 1,3,4-oxadiazoles 11a–d. Furthermore, two of the prepared compounds were examined to show the ability to activate MAO-B. In addition a number of prepared compounds showed antibacterial and antiviral activities.

1. Introduction

C-glycosides have received a great deal of attention from the synthesis and medicinal chemistry community, due to their increased stability to hydrolysis as well as their presence in a number of interesting natural products [1]. Furthermore, heterocyclic compounds containing the five-membered oxadiazole nucleus possess a diversity of useful biological effects. Substituted 1,3,4-oxadiazoles are of considerable pharmaceutical interest, for instance, 2-amino-1,3,4-oxadiazoles act as muscle relaxants [2] and show antimitotic activity. Anti-inflammatory [3,4], antimicrobial [4], anti-hepatitis B [5] and anti-diarrheal activity [6] of some new 1,3,4-oxadiazole derivatives was also reported. Recently several 1,3,4-oxadiazole derivatives were identified as potentially active antimycobacterial [7,8], antitubercular [9], anticonvulsant [10] and anticancer [11] agents, and also reported as enzyme tyrosinase inhibitors [12]. In light of these interesting biological activities, it became interested in synthesizing some new C-glycosides of substituted 1,3,4-oxadiazole derivatives and evaluating their antimicrobial potential.

2. Results and Discussion

2.1. Chemistry

It has been shown [13] that the acid-catalysed, intramolecular dehydration of 1b using conc. HCl (0 °C) yields a mixture of a major D-ribo anhydro isomer 2b (with inversion of configuration), and a minor D-arabino-anhydro isomer 4b (with retention of configuration). On the other hand, the dehydration of 1a with aqueous acetic acid (10%) under reflux [14], afforded a mixture of anhydro derivatives 2a (major isomer) and 4a (the minor one) and in addition, a mixture of 2b and 4b were obtained from 1b using aqueous acetic acid (10%). The minor isomer 4a could be isolated as a solid.
The anomeric configurations [15] of these anhydro derivatives were ascertained from the 1H-NMR spectra of their isopropylidene derivatives 3a,b which were prepared by an improved procedure [16] through treatment of the crude anhydro derivatives with acetone in the presence of catalytic amount of p-toluenesulphonic acid (see Experimental and Scheme 1).
Molecules 17 07010 g003 550
Scheme 1. Synthesis of isopropylidene derivatives 3a,b.
Scheme 1. Synthesis of isopropylidene derivatives 3a,b.
Molecules 17 07010 g003
1H-NMR spectra (CDCl3) of compounds 3a,b displayed the two methyl protons signals of the 2,2-dimethyldioxolane ring at δ (1.544–1.352) having Δδ 0.187. The signals of the sugar protons of these isopropylidene derivatives were assigned from the 2D 1H-NMR spectrum of compound 3b (Figure 1), and the characteristic chemical shifts as compared with those reported for anhydro analogues [16], whereby the C-1' proton appears as a singlet at δ 5.00 (J1',2' = 0.00 Hz). Confirmation of the anomeric configuration of the isopropylidene derivatives 3a,b can be obtained from the zero coupling constant value (J1',2' = 0.00 Hz), which is an unequivocal [16,17] proof for the trans arrangement of the H-1' and H-2' (β-D-configuration) as well as from the Δδ value (0.187) [15,18,19]. Boiling of the crude 2b,4b mixture with hydrazine hydrate resulted in the formation of 6, which upon condensation with a number of aldehydes afforded the corresponding anhydrohydrazone derivatives 7a–e which were also obtained as only one isomer (inversion of configuration at C-1') by boiling the compounds 12a–e [20,21] with aqueous acetic acid under reflux. The assignment of the signals for the sugar protons in the 1H-NMR spectra of compounds 7a–e were based on the 2D 1H-NMR spectrum of compound 7e. In addition, acetylation of the anhydrohydrazones 7a,d afforded the corresponding O-acetyl derivatives 8a,d, respectively (see Experimental and Scheme 2).
Molecules 17 07010 g001 550
Figure 1. 2D 1H-NMR spectrum of compound 3b.
Figure 1. 2D 1H-NMR spectrum of compound 3b.
Molecules 17 07010 g001
Molecules 17 07010 g004 550
Scheme 2. Synthesis of carbohydrazone derivatives.
Scheme 2. Synthesis of carbohydrazone derivatives.
Molecules 17 07010 g004
Periodate oxidation [22] of the prepared anhydro-derivatives 2b,4b, gave the corresponding dialdehyde in the hemialdal structure 9 [22,23]. Furthermore, condensation of dialdehyde 9 with two molar equivalents of aroylhydrazines, afforded the corresponding bisaroylhydrazones 10a–d. 1H-NMR spectra of compounds 10a–d (DMSO-d6), showed the two (NH) protons at δ (11.78–11.55) as two singlets, followed by the aromatic protons as a multiplet at δ (7.82–7.00), two (CH=N) as a doublet at 7.9 for H(2) and a multiplet at 7.7 for H(1), and the proton at position-4 in the furan ring as a singlet at 6.7 ppm. The methine proton was shown as a doublet at δ 5.1, followed by a multiplet at 4.1 ppm for the protons of the two methylene groups. Oxidative cyclization of the prepared bisaroylhydrazones 10a–d and a physical and chemical study of the oxidation products, revealed that their properties could not be reconciled with that of 1,2,3-triazole derivatives C [24,25,26,27] but rather was compatible with that of 1,3,4-oxadiazole derivatives 11a–d, that were obtained in appropriate yields. Infrared spectra of these compounds showed no enol benzoate group as expected for the 1,2,3-triazole derivatives C, and showed instead a band at 1,667–1,660 cm−1, which was attributed to the conjugated carbonyl group of compounds 11a–d (see Experimental and Scheme 3 and Scheme 4).
Furthermore, 1H-NMR spectra (CDCl3) of these products showed the disappearance of signals corresponding to two (NH) and two (CH=N), methine and methylene protons. Indeed, it is noteworthy that the integration of the aromatic part (δ 8.22–7.36 ppm), referred to one aromatic ring only, in accord with structures 11a,b,d. In addtion, these oxidative cyclization products displayed the proton at position-4 in the furan ring as the most downfield signal at δ (8.49–8.48) ppm; this proton resonated at a lower field region than that expected in CDCl3, which may be attributed to the electron withdrawing effect of the carbonyl group on the neighboring carbon atom, as well as conjugation with the phenyl oxadiazole moiety. In addition, the structure of the oxidation products 11a–d was further supported through their boiling with hydrochloric acid, which didn’t afford the corresponding amine derivatives D as expected from 1,2,3-triazole derivatives (see Experimental part and Scheme 4). Moreover, the proposed mechanism for formation of 11a–d may proceed via elimination of one aroylhydrazone part (oxidation in presence of iodine and mercuric oxide) due to the bulkiness of the molecule, followed by oxidative cyclization of the other aroylhydrazone part to afford compounds 11a–d (Scheme 5).
Molecules 17 07010 g005 550
Scheme 3. Synthesis of bisaroylhydrazone derivatives 10a–d.
Scheme 3. Synthesis of bisaroylhydrazone derivatives 10a–d.
Molecules 17 07010 g005
Molecules 17 07010 g006 550
Scheme 4. Synthesis of 1,3,4-oxadiazole derivatives 11a–d.
Scheme 4. Synthesis of 1,3,4-oxadiazole derivatives 11a–d.
Molecules 17 07010 g006
Molecules 17 07010 g007 550
Scheme 5. Proposed mechanism for formation of ethyl 2-methyl-5-(5-aryl-1,3,4-oxadiazole-2-carbonyl)furan-3-carboxylate.
Scheme 5. Proposed mechanism for formation of ethyl 2-methyl-5-(5-aryl-1,3,4-oxadiazole-2-carbonyl)furan-3-carboxylate.
Molecules 17 07010 g007

2.2. Pharmacological Screening

2.2.1. MAO-B Activity

2.2.1.1. Effect of Tested Compounds on MAO-B

This study aimed to evaluate the effect of two selected newly prepared compounds 7c,e on MAO-B activity given the biological importance of MAO-B [28,29,30,31,32,33,34,35,36,37,38].

2.2.1.2. Determination of Vmax and Km

TheVmax and Km of the MAO-B catalyzed reaction in the presence or absence of each examined compound was carried out by plotting V against [S], each separately. The obtained results revealed that MAO-B was activated in the presence of compounds 7c and 7e, each separately, by 6.57- and 6.97-fold, respectively. In addition, the MAO-B catalyzed reactions in the presence of compounds 7c and 7e have Vmax equal to 0.49 and 0.71, respectively. Meanwhile the Km values were 1.72 and 1.32, respectively. Our obtained data showed that compound 7e was an effective MAO-B activator, which increases the affinity of substrate to bind with the active site of MAO-B enzyme. That may be attributed to the presence of highly conjugated system with the cinamyl group in 7e as compared with bulky furan ring in 7c (Table 1, Figure 2).
Table
Table 1. Effect of substrate concentration on the rate of MAO-B catalyzed reactions in presence of the examined compounds 7c and 7e, compared to control.
Table 1. Effect of substrate concentration on the rate of MAO-B catalyzed reactions in presence of the examined compounds 7c and 7e, compared to control.
Substrate conc.Rate
Control7c7e
0.25 × 10−30.0200.0680.222
0.50 × 10−30.0420.0850.240
1.00 × 10−30.0500.1510.315
1.50 × 10−30.1800.2500.363
2.00 × 10−30.2000.3220.440
3.00 × 10−30.2800.4300.560
4.00 × 10−30.3650.4810.674
5.00 × 10−30.3800.4980.700
Molecules 17 07010 g002 550
Figure 2. Effect of substrate concentration on the rate of MAO-B catalyzed reactions in the presence of the examined compounds 7c,e compared to control.
Figure 2. Effect of substrate concentration on the rate of MAO-B catalyzed reactions in the presence of the examined compounds 7c,e compared to control.
Molecules 17 07010 g002

2.2.2. Antibacterial and Antifungal Activities

The compounds 3b, 6, 7c,e, 10a–c and 11a,b,d have been studied for their antibacterial and antifungal activities against four bacterial species (Escherichia coli, Bacillus sp., Staphylococcus sp., and Sarcina sp.) and six fungal species (Aspergillus niger, Aspergillus fmigatus, Alternaria sp., Fusarium sp., Chaetomium sp., and Penicillium sp.) using the Nutrient Agar (NA) and Sabouraud Dextrose Agar (SDA) diffusion methods, respectively, in DMSO solvent (Table 2).
Table
Table 2. Inhibition zones of tested compounds against selected microorganisms (mm).
Table 2. Inhibition zones of tested compounds against selected microorganisms (mm).
Compound No.Bacteria
Gram positiveGram negative
Bacillus sp.Sarcina sp.Staphylococcus sp.E. coli
3b….….….….
6….….2….
7c….….0.5….
7e….….2….
10a….….….….
10b….….….….
10c….….….….
11a….….1….
11b….….….….
11d….….….….
Compound No.Fungi
Aspergillus nigerAspergillus fumigatusAlternariasp.Fusarium sp.Chaetomium sp.Penicilliu sp.
3b11….2….….
6….….1122
7c110.52….0.5
7e….2.50.52….1
10a….….….….….….
10b1….….….….….
10c1….….….….….
11a0.5….0.5….….2
11b….….….….….….
11d….….….2….….
….: No effect.
It was found that they were active against Gram positive bacteria (Staphylococcus sp.). In addition, the replacement of the bulky furan ring in compound 7c by the cinamyl group in compound 7e, increased the antibacterial activity against Gram positive bacteria (Staphylococcus sp.), due to the conjugation caused by the cinamyl group [39]. With respect to antifungal activity, the compounds 3b, 6, 7c,e, and 11a were found to be generally active against the tested fungi.

3. Experimental

3.1. Chemistry

Melting points were determined with a Melt-temp. apparatus and are uncorrected. TLC was performed on Baker-Flex silica gel 1B-F plates and the spots were detected by UV light absorption. IR spectra were recorded on Perkin Elmer. USA Spectrometer. 1H-NMR, 13C-NMR, and 2D 1H-NMR were recorded on a JEOL JNM ECA 500 MHz instrument using tetramethylsilane as an internal standard. Mass spectra were recorded on GCMS solution DI Analysis Shimadzu Qp-2010 Plus. Optical rotation was obtained at 22 °C with a Perkin-Elmer Model 241 Polarimeter 10 cm, 1 mL microcell. Microanalyses were performed at the faculty of Science, Cairo University, Cairo, Egypt. Solutions were evaporated under diminished pressure unless otherwise stated. The ChemDraw-Ultra-8.0 has been used in generating the nomenclature of the prepared compounds.

3.1.1. Ethyl 5-(2',3'-Dihydroxytetrahydrofuran-1'-yl)-2-methylfuran-3-carboxylates 2b,4b

Compound 1b (15.0 g, 54.74 mmol) was boiled under reflux with aqueous acetic acid (300 mL, 10%) for 5 h, while the reaction was monitored by TLC (chloroform-methanol, 20:1, V/V), the starting material disappeared and a more mobile spot (Rf: 0.5) was obtained. The solvent was evaporated under diminished pressure and washed with toluene (3 times, 10 mL each) to obtain 2b as a yellow thick syrup along with a solid mass of 4b. Separation of 4b from the syrup was carried out by washing the mixture with ethanol where it was partially soluble in ethanol on cold; the overall yield was 69.7%; the solid mass was recrystallized from ethanol as colourless needles; IR (KBr): 3,426 (OH), 1,712 cm−1 (CO-ester).

3.1.2. Synthesis of Isopropylidene Derivatives

General Methods. A solution of 2a,4a[22] or 2b,4b mixture (4.42 mmol) in dry acetone (100 mL) was treated with p-toluenesulphonic acid (10.98 mmol) and stirred at room temperature. The reaction mixture was monitored by TLC (hexane-ethyl acetate, 7:1, V/V), the starting material disappeared after 7 h and a more mobile spot appeared. The mixture was then poured onto a saturated solution of sodium bicarbonate, extracted with chloroform, the organic layer washed with water and dried over anhydrous sodium sulphate. Evaporation of the dried filtrate gave pale yellow needles.
1-[5-(2',3'-O-Isopropylidene-β-D-erythrofuranosyl)-2-methylfuran-3-yl]ethanone (3a). Yield 51%; recrystallized from ethanol as colourless needles, mp 97–99 °C; Rf: 0.35 (hexane-ethyl acetate, 7:1, V/V), IR (KBr): 1,682 (CO-acetyl), 1,604, 1,571 cm−1 (C=C); 1H-NMR (CDCl3); δ: 1.358, 1.544 (2s, 6H, CMe2, Δδ 0.187), 2.376 (s, 3H, COCH3), 2.559 (s, 3H, CH3(furan)), 3.909 (dd, 1H, H-4'a, J3',4'a = 3.85 Hz, J4'b,4'a = 10.70 Hz), 4.049 (d, 1H, H-4'b, J4'b,4'a = 10.70 Hz), 4.892–4.937 (m, 2H, H-2', H-3'), 5.001 (s, 1H, H-1'), 6.475 (s, 1H, CHfuran); MS: m/z (%), 267 (3.50, M++1), 266 (4.82, M+), 137 (36.26), 125 (21.36), 111 (35.32), 109 (21.18), 99 (21.56), 97 (52.51), 95 (33.70), 85 (46.86), 83 (49.75), 81 (32.98), 73 (26.34), 71 (66.24), 69 (61.30), 67 (23.40), 60 (25.40), 57 (100), 56 (21.33), 55 (65.29).
Ethyl 5-(2',3'-O-isopropylidene-β-D-erythrofuranosyl)-2-methylfuran-3-carboxylate (3b). Yield (90%); recrystallized from ethanol as colourless needles, mp 70–72 °C; Rf: 0.63 (hexane-ethyl acetate, 7:1, V/V); [a] Molecules 17 07010 i001 −69.03; IR (KBr): 1,709 (CO-ester) 1,613, 1,583 cm−1 (C=C); 1H-NMR (CDCl3); δ: 1.324 (t, 3H, CH3(ester), J = 6.90 Hz), 1.352, 1.538 (2s, 6H, CMe2, Δδ 0.187), 2.542 (s, 3H, CH3(furan)), 3.870 (dd, 1H, H-4'a, J3',4'a = 3.80 Hz, J4'b,4'a = 10.70 Hz), 4.029 (d, 1H, H-4'b, J4'b,4'a = 10.70 Hz), 4.260 (q, 2H, CH2(ester), J = 6.90 Hz), 4.876–4.928 (m, 2H, H-2', H-3'), 5.003 (s, 1H, H-1'), 6.486 (s, 1H, CHfuran); MS: m/z (%), 297 (6.3, M++1), 296 (20.6, M+), 182 (100), 181 (30.6), 145 (60), 153 (43), 137 (25), 136 (25.6), 105 (21.3), 80 (27.5), 79 (28.8), 69 (38.1), 65 (28.8), 60 (13.8), 59 (76.3), 56 (25), 55 (30.6), 53 (33.8), 52 (44.4), 51 (60), 50 (25).
5-(2',3'-Dihydroxytetrahydrofuran-1'-yl)-2-methylfuran-3-carbohydrazide (6). A solution of 2b,4b (2.0 g, 7.81 mmol) in ethanol (10 mL) was treated with hydrazine hydrate (4 mL) under reflux for one hour, while the reaction was monitored by TLC (chloroform-methanol, 6:1, V/V) which revealed the absence of the starting material and formation of two more mobile spots, Rf: 0.49 (major) and 0.74 (minor). After cooling 6 separated out, was filtered off, washed with a little ethanol, and dried; yield 65%. It was recrystallized from ethanol as colourless needles, mp 185–187 °C. TLC showed one spot only, Rf: 0.49 (chloroform-methanol, 6:1, V/V); The minor isomer was left in the mother liquor; [a] Molecules 17 07010 i001 −58.98; IR (KBr): 3,384, 3,314 (OH and NH2), 3272 (NH), 1,636 cm−1 (CO-amide); 1H-NMR (DMSO-d6); δ: 2.463 (s, 3H, CH3(furan)), 3.570 (dd, 1H, H-4'b, J3',4'b = 2.30 Hz, J4'b,4'a = 9.15 Hz), 3.979 (dd, 1H, H-4'a, J3',4'a = 4.60 Hz, J4'b,4'a = 9.15 Hz), 4.029–4.066 (m, 2H, H-3', H-2'), 4.312 (s, 2H, NH2), 4.395 (d, 1H, H-1', J1',2' = 6.90 Hz), 4.985 (d, 1H, 2'-OH, J2',OH = 4.60 Hz), 5.076 (d, 1H, 3'-OH, J3',OH = 6.85 Hz), 6.715 (s, 1H, CHfuran), 9.243 (s, 1H, NH). After shaking with D2O, the NH, NH2, and the two hydroxyl protons disappeared; MS: m/z (%), 243 (2.19, M++1), 242 (16.89, M+), 224 (0.47, M+-H2O), 212 (11.54, M+-2NH), 211 (100, M+-NHNH2); Anal. Calcd for C10H14N2O5: C, 49.58; H, 5.84; N, 1.55%; found: C, 49.58; H, 5.83; N, 1.56%.

3.1.3. Reactions of 6 with a Number of Aldehydes

General Methods

Method A. A solution of 6 (0.5 g, 2.066 mmol) in ethanol (5 mL) containing acetic acid (0.1 mL) was treated with the corresponding aldehyde (2.066 mmol), and the reaction mixture was refluxed on water bath for 10 min. After cooling the product 3-carbohydrazone derivative that separated out, was filtered off, washed with little ethanol, and dried.
Method B. A solution of (1',2',3',4'-tetrahydroxybutyl)furan-3-carbohydrazone 12a–e [20,21] (4.799 mmol) was refluxed with aqueous acetic acid (10%) for 5 h. After cooling the compounds 7a–e that separated out as a crystalline mass were filtered off, washed with little ethanol, and dried.
5-(2',3'-Dihydroxytetrahydrofuran-1'-yl)-2-methyl-N-[(2-phenyl-2H-1,2,3-triazol-4-yl)methyl-ene]furan-3-carbohydrazone (7a). Yield of method A 87%; recrystallized from ethanol as colourless needles, mp 209–210 °C; Rf: 0.39 (chloroform-methanol, 15:1, V/V); [a] Molecules 17 07010 i001 −37.59; IR (KBr): 3,395 (OH), 3,108 (NH), 1,669 (CO-amide), 1,638 cm−1 (C=N); 1H-NMR (DMSO-d6); δ: 2.524 (s, 3H, CH3(furan)), 3.616 (dd, 1H, H-4'b, J3',4'b = 2.30 Hz, J4'b,4'a = 9.20 Hz), 4.008–4.026 (m, 1H, H-4'a), 4.036–4.095 (m, 2H, H-3', H-2'), 4.493 (d, 1H, H-1', J1',2' = 6.90 Hz), 5.043 (ss, 1H, 2'-OH), 5.142 (d, 1H, 3'-OH, J3',OH = 6.15 Hz), 6.860 (s, 1H, CHfuran), phenyl protons: 7.432 (t, 1H,p-H), 7.568 (t, 2H, O-H), 8.017 (d, 2H, m-H), 8.401 (s, 1H, CH=N), 8.537 (s, 1H, CHtriazole), 11.610 (s, 1H, NH). After shaking with D2O, the NH proton and the two hydroxyl protons disappeared; MS: m/z (%), 399 (0.89, M++2), 398 (5.36, M++1), 397 (23.99, M+), 379 (3.55, M+-H2O), 324 (21.85), 253 (11.94, M+-phenyltriazole moiety), 211 (100), 137 (35.81), 77 (20.56, C6H5); Anal. Calcd for C19H19N5O5: C, 57.42; H, 4.80; N, 17.64%; found: C, 57.43; H, 4.82; N, 17.62%.
N-[(2-(p-Bromophenyl)-2H-1,2,3-triazol-4-yl)methylene]-5-(2',3'-dihydroxytetrahydrofuran-1'-yl)-2-methylfuran-3-carbohydrazone (7b). Yield of method A 84%; recrystallized from ethanol as colourless needles, mp 241–243 °C; Rf: 0.38 (chloroform-methanol, 15:1, V/V); [a] Molecules 17 07010 i001 −31.39; IR (KBr): 3,423 (OH), 3,249 (NH), 1,653 (CO-amide), 1,618 cm−1 (C=N); 1H-NMR (DMSO-d6); δ: 2.519 (s, 3H, CH3(furan)), 3.617 (dd, 1H, H-4'b, J3',4'b = 2.30 Hz, J4'b,4'a = 9.95 Hz), 4.019 (dd, 1H, H-4'a, J3',4'a = 3.85 Hz, J4'b,4'a = 9.95 Hz), 4.080–4.109 (m, 2H, H-3', H-2'), 4.493 (d, 1H, H-1', J1',2' = 6.90 Hz), 5.051 (ss, 1H, 2'-OH), 5.147 (d, 1H, 3'-OH, J3',OH = 6.10 Hz), 6.857 (s, 1H, CHfuran), p-bromophenyl protons: 7.752 (d, 2H, m-H), 7.954 (d, 2H, o-H), 8.422 (s, 1H, CH=N), 8.518 (s, 1H, CH(triazole)), 11.630 (s, 1H, NH). After shaking with D2O, the NH proton and the two hydroxyl protons disappeared; 13C-NMR; δ: 14.00 (C-13), 70.91 (C-4'), 73.32 (C-3'), 75.33 (C-2'), 76.50 (C-1'), 107.79 (C-12), 115.11 (C-11), 120.92 (C-10), 121.23 (C-9), 133.27 (C-8), 135.16 (C-7), 137.74 (C-6), 138.52 (C-5), 146.50 (C-4), 151.71 (C-3), 158.19 (C-2), 159.84 (C-1); MS: m/z (%), 478/476 (2.03, 2.17, M++1), 477/475 (8.85, 9.10, M+), 459/457 (1.25, 1.24, M+-H2O), 253 (10.01, M+-p-bromophenyl triazole moiety), 211 (100), 137 (34); Anal. Calcd for C19H18BrN5O5: C, 47.90; H, 3.83; N, 14.71; Br, 16.77%; found: C, 47.91; H, 3.81; N, 14.70; Br, 16.78%.
Ethyl 5-[(2-(5-(2',3'-dihydroxytetrahydrofuran-1'-yl)-2-methylfuran-3-carbonyl)hydrazono)-methyl]-2-methylfuran-3-carboxylate (7c). Yield of method A 93%; [a] Molecules 17 07010 i001 −44.42; IR (KBr): 3,426 (OH), 3,208 (NH), 1,694 (CO-ester), 1,655 (CO-amide), 1,616 cm−1 (C=N); 1H-NMR (DMSO-d6); δ: 1.254 (t, 3H, CH3(ester), J = 7.65 Hz), 2.501 (s, 3H, CH3(furan-1)), 2.580 (s, 3H, CH3(furan-2)), 3.603 (dd, 1H, H-4'b, J3',4'b = 2.30 Hz, J4'b,4'a = 9.90 Hz), 4.004 (dd, 1H, H-4'a, J3',4'a = 4.60 Hz, J4'b,4'a = 9.90 Hz), 4.043–4.088 (m, 2H, H-3', H-2'), 4.209 (q, 2H, CH2(ester), J = 7.65 Hz), 4.467 (d, 1H, H-1', J1',2' = 6.85 Hz), 5.028 (d, 1H, 2'-OH, J2',OH = 3.80 Hz), 5.124 (d, 1H, 3'-OH, J3',OH = 6.10 Hz), 6.830 (s, 1H, CHfuran-1), 7.059 (s, 1H, CHfuran-2), 8.150 (s, 1H, CH=N), 11.409 (s, 1H, NH). After shaking with D2O, the NH proton and the two hydroxyl protons disappeared; MS: m/z (%), 408 (0.79, M++2), 407 (4.16, M++1), 406 (18.26, M+), 211 (100), 154 (32.75); Anal. Calcd for C19H22N2O8: C, 56.13; H, 5.47; N, 6.86%; found: C, 56.15; H, 5.46; N, 6.89%.
N-Benzylidene-5-(2',3'-dihydroxytetrahydrofuran-1'-yl)-2-methylfuran-3-carbohydrazone (7d). Yield of method A 84%; recrystallized from ethanol as colourless needles, mp 86–88 °C; Rf: 0.345 (chloroform-methanol, 15:1, V/V); [a] Molecules 17 07010 i001 −42.16; IR (KBr): 3,380 (OH and NH), 1,661 (CO-amide), 1,616 cm−1 (C=N); 1H-NMR (DMSO-d6); δ: 2.513 (s, 3H, CH3(furan)), 3.608 (dd, 1H, H-4'b, J3',4'b = 2.30 Hz, J4'b,4'a = 9.95 Hz), 4.012 (dd, 1H, H-4'a, J3',4'a = 4.60 Hz, J4'b,4'a = 9.95 Hz), 4.065–4.089 (m, 2H, H-3', H-2'), 4.476 (d, 1H, H-1', J1',2' = 6.90 Hz), 5.043 (d, 1H, 2'-OH, J2',OH = 3.85 Hz), 5.141 (d, 1H, 3'-OH, J3',OH = 6.10 Hz), 6.869 (s, 1H, CH(furan)), phenyl protons: 7.395–7.436 (m, 3H, p-H, O-H), 7.672 (d, 2H, m-H), 8.340 (s, 1H, CH=N), 11.389 (s, 1H, NH). After addition of D2O, the NH proton and the two hydroxyl protons disappeared; MS: m/z (%), 331 (2.25, M++1), 330 (10.80, M+), 227 (9.18, M+-C6H5CN), 211 (100), 154 (59.63), 77 (9.32, C6H5); Anal. Calcd for C17H18N2O5: C, 61.80; H, 5.50; N, 8.45%; found: C, 61.8; H, 5.49; N, 8.48%.
5-(2',3'-Dihydroxytetrahydrofuran-1'-yl)-2-methyl-N-(3-phenylallylidene)furan-3-carbohydrazone (7e). Yield of method A 92.5%; recrystallized from ethanol as colourless needles, mp 162–163 °C; Rf: 0.78 (chloroform:-methanol, 10:1, V/V); [a] Molecules 17 07010 i001 −42.55; IR (KBr): 3,409 (OH), 3,241 (NH), 1,657 (CO-amide), 1,628 cm−1 (C=N); 1H-NMR (DMSO-d6); δ: 2.499 (s, 3H, CH3(furan)), 3.598–3.617 (m, 1H, H-4'b), 4.013 (dd, 1H, H-4'a, J3',4'a = 3.80 Hz, J4'b,4'a = 9.90 Hz), 4.026–4.104 (m, 2H, H-3', H-2'), 4.476 (d, 1H, H-1', J1',2' = 6.90 Hz), 5.025 (d, 1H, 2'-OH, J2',OH = 3.80 Hz), 5.121 (d, 1H, 3'-OH, J3',OH = 6.15 Hz); 6.849 (s, 1H,CHfuran), 7.00 (bs, 2H, CH=CH), phenyl protons: 7.273–7.302 (m, 1H, p-H), 7.355 (t, 2H, O-H), 7.585 (d, 2H, m-H); 8.124 (d, 1H, CH=N, J = 6.15 Hz), 11.264 (s, 1H, NH); MS: m/z (%), 358 (0.21, M++2), 357 (0.95, M++1), 356 (3.22, M+), 338 (0.11, M+-H2O), 320 (0.21, M+-2H2O), 279 (0.52, M+-C6H5), 211 (100), 154 (55.50), 130 (35.56), 77 (8.65, C6H5), 43 (49, COCH3); Anal. Calcd for C19H20N2O5: C, 64.03; H, 5.64; N, 7.84%; found: C, 64.04; H, 5.66; N, 7.86%.

3.1.4. Reactions of Compounds 7a,d with Acetic Anhydride

General Method: A solution of the sugar derivative 7a or 7d (1.51 mmol) in a mixture of pyridine (15 mL) and acetic anhydride (15 mL) was kept overnight at room temperature with occasional shaking. Then it was poured onto crushed ice, the di-O-acetyl derivative that separated out, was filtered off, washed with water, and dried.
1'-[2-Methyl-3-(2-((2-phenyl-2H-1,2,3-triazol-4-yl)methylene)hydrazinecarbonyl)furan-5-yl]-tetra-hydrofuran-2',3'-diyl diacetate (8a). Yield 76.5%; recrystallized from dilute ethanol as colourless needles, mp 179–181 °C; Rf 0.5 (hexane-ethyl acetate, 2:1, V/V); [a] Molecules 17 07010 i001 −47.75; IR (KBr): 3,217 (NH), 1,754 (OAc), 1,647 (CO-amide), 1,601 cm−1 (C=N); 1H-NMR (CDCl3); δ: 2.061, 2.139 (2s, 6H, 2OAc), 2.677 (s, 3H, CH3(furan)), 3.984–3.968 (m, 1H, H-4'b), 4.371 (dd, 1H, H-4'a, J3',4'a = 4.60 Hz, J4'b,4'a = 9.95 Hz), 4.925 (d, 1H, H-1', J1',2' = 6.10 Hz), 5.492–5.532 (m, 2H, H-3', H-2'), 6.744 (bs, 1H, CHfuran), 7.462–7.478 (m, 1H, p-H), 7.531–7.625 (m, 2H, O-H), 8.019–8.141 (m, 4H, m-H, CH=N, CHtriazole), and 12.239 (s, 1H, NH); MS: m/z (%), 482 (0.61, M++1), 481 (1.97, M+), 363 (22.58), 362 (100), 295 (67.47), 137 (21.53), 115 (19.79), 77 (15.78); Anal. Calcd for C23H23N5O7: C, 57.35; H, 4.82; N, 14.53%; found: C, 57.38; H, 4.82; N, 14.55%.
1'-[3-(2-Benzylidenehydrazinecarbonyl)-2-methylfuran-5-yl]tetrahydrofuran-2',3'-diyl diacetate (8d). Yield 80%; recrystallized from dilute methanol as colourless needles, mp 81–82 °C; Rf 0.5 (hexane-ethyl acetate, 2:1, V/V); [a] Molecules 17 07010 i001 −48.37; IR (KBr): 3,248 (NH), 1,752 (OAc), 1,654 (CO-amide), 1,582 cm−1 (C=N); 1H-NMR (CDCl3); δ: 2.070, 2.125 (2s, 6H, 2OAc), 2.602 (s, 3H, CH3(furan)), 3.954–3.974 (m, 1H, H-4'b), 4.381–4.350 (m, 1H, H-4'a), 4.950 (bs, 1H, H-1'), 5.417–5.524 (m, 2H, H-3', H-2'), 6.620 (s, 1H, CHfuran), 7.519–7.549 (m, 5H, phenyl protons), 7.883 (d, 1H, CH=N, J = 7.65 Hz), 9.550 (s, 1H, NH); MS: m/z (%), 415 (0.39, M++1), 414 (0.81, M+), 295 (100), 77 (2.61); Anal. Calcd for C21H22N2O7: C, 60.86; H, 5.37; N, 6.77%; found: C, 60.86; H, 5.35; N, 6.76%.
Ethyl 5-(3,5-dihydroxy-1,4-dioxan-2-yl)-2-methylfuran-3-carboxylate (9). A solution of 2b,4b mixture (12.96 g, 50.62 mmol) in distilled water (20 mL) was treated dropwise with a solution of sodium metaperiodate (10.825 g, 50.62 mmol) in distilled water (20 mL) with continuous stirring for 3 h. The dialdehyde that separated out was filtered off, washed with little water, and dried, yield 67%; Rf: 0.38 (chloroform-methanol, 15:1, V/V). Recrystallized from ethanol as colourless needles, mp 111–113 °C (Lit. [22], 111–113 °C); IR (KBr): 3,426 (OH), 1,712 cm−1 (CO-ester); 1H-NMR (CDCl3); δ: 1.293–1.326 (m, 3H, CH3(ester)), 2.519 (s, 3H, CH3(furan)), 3.380–3.428 (m, 1H, H-6b), 3.745–3.947 (m, 1H, H-6a), 4.222–4.387 (m, 2H, 3-OH, 5-OH), 4.275 (q, 2H, CH2(ester)), 4.609–4.745 (m, 1H, H-5), 5.112–5.125 (m, 1H, H-3), 5.514–5.534 (m, 1H, H-2), and 6.677 (s, 1H, CHfuran).

3.1.5. Reactions of 9 with a Number of Aroylhydrazines

General Method: A solution of 9 (2.0 g, 7.353 mmol) in ethanol (10 mL) containing acetic acid (0.1 mL) was treated with the corresponding aroylhydrazine (14.71 mmol) in ethanol (10 mL). The reaction mixture was refluxed on water bath for 15 min, the bisaroylhydrazone derivative that separated out was filtered off, washed with little ethanol, and dried.
Ethyl 5-[2-(2-benzoylhydrazono)-1-(2-(2-benzoylhydrazono)ethoxy)ethyl]-2-methylfuran-3-carboxylate (10a). Yield 61%; recrystallized from ethanol-chloroform as colourless needles, mp 204–206° C; Rf: 0.55 (chloroform-methanol, 10:1, V/V); IR (KBr): 3,280, 3,197 (2NH), 1,715 (CO-ester), 1,658 (CO-amide), 1,591 cm−1 (C=N); 1H-NMR (DMSO-d6); δ: 1.223 (t, 3H, CH3(ester), J = 6.90 Hz ), 2.524 (s, 3H, CH3(furan)), 4.086–4.199 (m, 4H, CH2, CH2(ester)), 5.150 (d, 1H, CH, J = 6.85 Hz), 6.736 (s, 1H, CHfuran), phenyl protons: 7.472–7.476 (m, 4H, O-H), 7.550–7.546 (m, 2H, p-H), 7.794–7.837 (m, 4H, m-H), 7.719 (bs, 1H, CH=N1), 7.912 (d, 1H, CH=N2, J = 6.10 Hz), 11.673 (s, 1H, NH3), 11.777 (s, 1H, NH4); MS: m/z (%), 472 (0.57, M+-H2O), 354 (56.88), 181 (31.16), 173 (29.44), 153 (23.60), 147 (93.31), 121 (41.45), 106 (49.34), 105 (100), 104 (23.78), 78 (21.08), 77 (99.13), 51 (77.47), 50 (24.02); Anal. Calcd for C26H26N4O6: C, 63.65; H, 5.35; N, 11.43%; found: C, 63.66; H, 5.34; N, 11.42%.
Ethyl 5-[2-(2-(p-toluoyl)hydrazono)-1-(2-(2-(p-toluoyl)hydrazono)ethoxy)ethyl]-2-methylfuran-3-carboxylate (10b). Yield 58%; recrystallized from ethanol-chloroform as colourless needles, mp 204–206 °C; Rf: 0.22 (chloroform-methanol, 15:1, V/V); IR (KBr): 3,305, 3,183 (2NH), 1,717 (CO-ester), 1,651 (CO-amide), 1,625, 1,612 cm−1 (C=N); 1H-NMR (DMSO-d6); δ: 1.222 (t, 3H, CH3(ester), J = 6.85 Hz), 2.327 (s, 6H, 2CH3(toluoyl)), 2.522 (s, 3H, CH3(furan)), 4.103–4.196 (m, 4H, CH2, CH2(ester)), 5.132 (d, 1H, CH, J = 6.90 Hz), 6.727 (s, 1H, CHfuran), aromatic protons: 7.265–7.280 (m, 4H, O-H), 7.708–7.747(m, 5H, m-H, CH=N1), 7.899 (d, 1H, CH=N2, J = 6.10 Hz), 11.601 (s, 1H, NH3), 11.716 (s, 1H, NH4); MS: m/z (%), 518 (0.09, M+), 500 (0.18, M+-H2O), 368 (31.86), 161 (44.53), 161 (44.53), 119 (100), 91 (50.53), 65 (19.49); Anal. Calcd for C28H30N4O6: C, 64.87; H, 5.85; N, 10.78%; found: C, 64.85; H, 5.83; N, 10.80%.
Ethyl 5-[2-(2-(p-anisoyl)hydrazono)-1-(2-(2-(p-anisoyl)hydrazono)ethoxy)ethyl]-2-methylfuran-3-carboxylate (10c). Yield 57%; recrystallized from ethanol-chloroform as colourless needles, mp 204–206 °C; Rf: 0.32 (chloroform:-methanol, 10:1, V/V); IR (KBr): 3,268, 3,212 (2NH), 1,718 (CO-ester), 1,645 (CO-amide), 1,610 cm−1 (C=N); 1H-NMR (DMSO-d6); δ: 1.225 (t, 3H, CH3(ester), J = 6.15 Hz), 2.525 (s, 3H, CH3(furan)), 3.776 (s, 6H, 2OCH3), 4.156–4.199 (m, 4H, CH2, CH2(ester)), 5.127 (d, 1H, CH, J = 6.15 Hz), 6.726 (s, 1H, CHfuran), aromatic protons: 6.700–7.008 (m, 4H, m-H), 7.799–7.837 (m, 4H, O-H), 7.707 (bs, 1H, CH=N1), 7.895 (d, 1H, CH=N2, J = 6.10 Hz), 11.554 (s, 1H, NH3), 11.653 (s, 1H, NH4); MS: m/z (%), 532 (0.15, M+-H2O), 135 (100); Anal. Calcd for C28H30N4O8: C, 61.05; H, 5.47; N, 10.19%; found: C, 61.08; H, 5.49; N, 10.18%.
Ethyl 5-[2-(2-(p-chlorobenzoyl)hydrazono)-1-(2-(2-(p-chlorobenzoyl)hydrazono)ethoxy)ethyl]-2-methylfuran-3-carboxylate (10d). Yield 62%; recrystallized from ethanol-chloroform as colourless needles, mp 204–206 °C; Rf: 0.4 (chloroform-methanol, 15:1, V/V); IR (KBr): 3,270, 3,215 (2NH), 1,719 (CO-ester), 1,650 (CO-amide), 1,612 cm−1 (C=N); Anal. Calcd for C26H24Cl2N4O6: C, 55.80; H, 4.33; N, 10.02; Cl, 12.69%; found: C, 55.82; H, 4.32; N, 10.02; Cl, 12.68%.

3.1.6. Reactions of Compounds 10a–d with Yellow Mercuric Oxide

General Method: A solution of 10a–d (4.5 mmol) in dry ether (50 mL) was stirred with yellow mercuric oxide (3.0 g), magnesium oxide (0.3 g), and iodine (2.5 g) at room temperature for 48 h under anhydrous condition. The reaction mixture was filtered off, and the filtrate washed with potassium iodide solution, sodium thiosulphate, and water, respectively, then dried over anhydrous sodium sulphate. On evaporation of the dried filtrate a yellow syrup was obtained, which was crystallized from ethanol. An additional crop was obtained by extracting the inorganic residue with chloroform which upon concentration and dilution with ethanol yielded the same product.
Ethyl 2-methyl-5-(5-phenyl-1,3,4-oxadiazole-2-carbonyl)furan-3-carboxylate (11a). Yield 36%; recrystallized from ethanol as colourless needles, mp 168–170 °C; Rf: 0.41 (hexane-ethyl acetate, 6:1, V/V); IR (KBr): 1,715 (CO-ester), 1,660 (C=O), 1,594 cm−1 (C=N); 1H-NMR (CDCl3); δ: 1.391 (t, 3H, CH3(ester), J = 6.85 Hz), 2.778 (s, 3H, CH3(furan)), 4.344 (q, 2H, CH2(ester), J = 6.85 Hz), phenyl protons: 7.565 (t, 2H, O-H), 7.611-7.637 (m, 1H, p-H), 8.210-8.224 (m, 2H, m-H), 8.491 (s, 1H, CHfuran); MS: m/z (%), 328 (3.07, M++2), 327 (20.48, M++1), 326 (100, M+), 181 (22.15), 153 (32.73), 145 (61.44), 77 (49.04); Anal. Calcd for C17H14N2O5: C, 62.57; H, 4.32; N, 8.59%; found: C, 62.57; H, 4.33; N, 8.60%.
Ethyl 2-methyl-5-(5-(p-tolyl)-1,3,4-oxadiazole-2-carbonyl)furan-3-carboxylate (11b). Yield 39%; recrystallized from ethanol as colourless needles, mp 185–187 °C; Rf: 0.52 (hexane-ethyl acetate, 6:1, V/V); IR (KBr): 1,715 (CO-ester), 1,660 (C=O), 1,611 cm−1 (C=N); 1H-NMR (CDCl3); δ: 1.390 (t, 3H, CH3(ester), J = 6.90 Hz), 2.457 (s, 3H, CH3(tolyl)), 2.775 (s, 3H, CH3(furan)), 4.348 (q, 2H, CH2(ester), J = 6.90 Hz), phenyl protons: 7.361 (d, 2H, O-H), 8.098 (d, 2H, m-H), 8.482 (s, 1H, CHfuran); Anal. Calcd for C18H16N2O5: C, 63.53; H, 4.76; N, 8.25%; found: C, 63.52; H, 4.74; N, 8.23%.
Ethyl 2-methyl-5-[5-(p-anisyl)-1,3,4-oxadiazole-2-carbonyl]furan-3-carboxylate (11c). Yield 21%; recrystallized from ethanol as colourless needles, mp 182–183 °C; Rf: 0.41 (hexane-ethyl acetate, 6:1, V/V); IR (KBr): 1,714 (CO-ester), 1,657 (C=O), 1,606 cm−1 (C=N); Anal. Calcd for C18H16N2O6: C, 60.66; H, 4.55; N, 7.86%; found: C, 60.67; H, 4.53; N, 7.86%.
Ethyl 2-methyl-5-[5-(p-chlorophenyl)-1,3,4-oxadiazole-2-carbonyl]furan-3-carboxylate (11d). Yield 39%; recrystallized from ethanol as colourless needles, mp 177–178 °C; Rf: 0.59 (hexane-ethyl acetate, 6:1, V/V); IR (KBr): 1,723 (CO-ester), 1,667 (C=O), and 1,600 cm−1 (C=N); 1H-NMR (CDCl3); δ: 1.391 (t, 3H, CH3(ester), J = 6.85 Hz), 2.778 (s, 3H, CH3(furan)), 4.353 (q, 2H, CH2(ester), J = 6.85 Hz), p-chlorophenyl protons: 7.550 (d, 2H, m-H), 8.158 (d, 2H, O-H), 8.482 (s, 1H, CHfuran); 1H-NMR (DMSO-d6); δ: 1.293 (t, 3H, CH3(ester), J = 6.85 Hz), 2.692 (s, 3H, CH3(furan)), 4.269 (q, 2H, CH2(ester), J = 6.85 Hz), p-chlorophenyl protons: 7.700 (d, 2H, m-H), 8.082 (d, 2H,O-H), 8.170 (s, 1H, CHfuran); MS: m/z (%), 362/360 (100, 42, M+), 181 (78.7), 179 (71.29), 153 (78.02), 141/139 (11.12, 33.56), 137 (39.6), 113/111 (10.89, 33.86); Anal. Calcd for C17H13ClN2O5: C, 56.62; H, 3.64; N, 7.75; Cl, 9.81%; found: C, 56.60; H, 3.63; N, 7.77; Cl, 9.83%.

3.2. Pharmacological Screening

3.2.1. MAO-B Activity

3.2.1.1. Enzyme Preparation

Rabbit brain was homogenized in 9 volumes of ice-cold 0.1 M sodium phosphate buffer (pH 7.4) with an Ultra-Turrax 18/2 homogenizer. The separated mitochondrial fraction was suspended in phosphate buffer to give a final volume of 1 mL g−1 weight of tissue [40].

3.2.1.2. Enzyme Assay

Monoamine oxidase-B activity was assayed in presence and absence of the examined compounds each separately using benzylamine as substrate by continuous recording on a Pye Unicam SP8-100 Double Beam Spectrophotometer of the increase in extinction at 250 nm produced at 38 °C.

3.2.1.3. Determination of Vmax and Km

The Vmax and Km of MAO-B catalyzed reaction in presence or absence of each examined compound 7c and 7e was carried out by plotting the rate of the reaction (V) against substrate concentration [S], each separately.

3.2.2. Antibacterial and Antifungal Screening

The antibacterial and antifungal activities of synthesized compounds 3b, 6, 7c,e, 10a–c and 11a,b,d against four bacterial species (Escherichia coli, Bacillus sp., Staphylococcus sp., and Sarcina sp.) and six fungal species (Aspergillus niger, Aspergillus fmigatus, Alternaria sp., Fusarium sp., Chaetomium sp., and Penicillium sp.). have been studied by using the Nutrient Agar (NA) and Sabouraud Dextrose Agar (SDA) diffusion methods, respectively in DMSO solvent. The bacteria were subcultured on Nutrient Agar medium (NA), whereas, fungi were subcultured on Sabouraud Dextrose Agar (SDA). The composition is given in g/L unless otherwise stated. The pH value of the media was adjusted to 7 ± 0.1 prior to sterilization with 0.1 M sodium hydroxide or hydrochloric acid. All media were prepared with distilled water and sterilized by autoclaving at 121 °C for 20 min. Nutrient Agar (NB): Peptone, 5; beef extract, 3; NaCl, 5; agar, 20. Sabouraud Dextrose Agar (SDA): Peptone, 10; glucose, 40; agar, 20. The stock solutions (1 mg/mL) of the test chemicals were prepared by dissolving 10 mg of the test compounds in 10 mL dimethylsulphoxide (DMSO) solvent. Petri plates (150 mm × 15 mm) were prepared by pouring 60 mL of SDA and allowed to solidify. Plates were dried and 1 mL of each standardized inoculums suspension was poured and uniformly spread. The excess inoculums was drained and the inoculums was allowed to dry for 15 min. Eight equidistant wells were made in the medium using a sterile cork borer (6 mm in diameter and 50 μL of the test chemicals (1 mg/mL) diluted in DMSO 2% were placed into the wells. The Petri-dishes containing bacterial and fungi species were incubated at 37 °C for 24 h, and 48 h, respectively. The tests were carried in triplicate. The antimicrobial activity was measured as the diameter (mm) of clear zone of growth inhibition.

4. Conclusions

Some new C-glycoside derivatives and heterocyclic derivatives of carbohydrate have been prepared and their physical and biological properties were studied. It was found that compounds with highly conjugated systems are acting as MAO-B activators, as well as antibacterial agents, meanwhile all tested compounds have antifungal activities.

Acknowledgements

Thanks are due to Sallam, M.A., Faculty of Science, Alexandria University for optical rotation measurements, and El-Badn, D., Department of Botany, Faculty of Science, Alexandria University for microbiological studies.
  • Sample Availability: Samples of the compounds are available from the authors.

References

  1. Rainier, J.D.; Cox, J.M. Aluminum- and boron-mediated C-glycoside synthesis from 1,2-anhydro-glycosides. Org. Lett. 2000, 2, 2707–2709. [Google Scholar] [CrossRef]
  2. Yale, H.L.; Losee, K. 2-Amino-5-substituted 1,3,4-oxadiazoles and 5-imino-2-substituted Δ2-1,3,4-oxadiazolines. A group of novel muscle relaxants. J. Med. Chem. 1966, 9, 478–483. [Google Scholar] [CrossRef]
  3. Omar, F.A.; Mahfouz, N.M.; Rahman, M.A. Design, synthesis and anti-inflammatory activity of some 1,3,4-oxadiazole derivatives. Eur. J. Med. Chem. 1996, 31, 819–825. [Google Scholar] [CrossRef]
  4. Palusa, S.K.G.; Udupi, R.H.; Himabindu, V.; Sridhara, A.M. Synthesis and evaluation of a series of pyrimidine substituted 1,3,4-oxadiazole derivatives as antimicrobial and anti-inflammatory agents. Org. Commun. 2011, 4, 82–93. [Google Scholar]
  5. Tan, T.M.C.; Chen, Y.; Kong, K.H.; Bai, J.; Li, Y.; Lim, S.G.; Ang, T.H.; Lam, Y. Synthesis and the biological evaluation of 2-benzenesulfonyl alkyl-5-substituted-sulfanyl-(1,3,4)-oxadiazoles as potential anti-hepatitis B virus agents. Antiviral Res. 2006, 71, 7–14. [Google Scholar] [CrossRef]
  6. Adelstein, G.W.; Yen, C.H.; Dajani, E.Z.; Bianchi, R.G. 3,3-Diphenyl-3-(2-alkyl-1,3,4-oxadiazol-5-yl)propylcycloalkylamines, a novel series of antidiarrheal agents. Med. Chem. 1976, 19, 1221–1225. [Google Scholar] [CrossRef]
  7. Jha, K.K.; Samad, A.; Kumar, Y.; Shaharyar, M.; Khosa, R.; Jain, J.; Bansal, S. 3D-QSAR studies of 1,3,4-oxadiazole derivatives as antimycobacterial agents. Iran. J. Pharm. Res. 2009, 8, 163–167. [Google Scholar]
  8. Macaev, F.; Rusu, G.; Pogrebnoi, S.; Gudima, A.; Stingaci, E.; Vlad, L.; Shvets, N.; Kandemirli, F.; Dimoglo, A.; Reynolds, R. Synthesis of novel 5-aryl-2-thio-1,3,4-oxadiazoles and the study of their structure-anti-mycobacterial activities. Bioorg. Med. Chem. 2005, 13, 4842–4850. [Google Scholar] [CrossRef]
  9. Navarrete-Vazquez, G.; Molina-Salinas, G.M.; Duarte-Fajardo, Z.V.; Vargas-Villarreal, J.; Estrada-Soto, S.; Gonzalez-Salazar, F.; Hernandez-Nunez, E.; Said-Fernandez, S. Synthesis and antimycobacterial activity of 4-(5-substituted-1,3,4-oxadiazol-2-yl)pyridines. Bioorg. Med. Chem. 2007, 15, 5502–5508. [Google Scholar]
  10. Zarghi, A.; Tabatabai, S.A.; Faizi, M.; Ahadian, A.; Navabi, P.; Zanganeh, V.; Shafiee, A. Synthesis and anticonvulsant activity of new 2-substituted-5-(2-benzyloxyphenyl)-1,3,4-oxadiazoles. Bioorg. Med. Chem. Lett. 2005, 15, 1863–1865. [Google Scholar] [CrossRef]
  11. Jin, L.; Chen, J.; Song, B.; Chen, Z.; Yang, S.; Li, Q.; Hu, D.; Xu, R. Synthesis, structure, and bioactivity of N'-substituted benzylidene-3,4,5-trimethoxybenzohydrazide and 3-acetyl-2 substituted phenyl-5-(3,4,5-trimethoxyphenyl)-2,3-dihydro-1,3,4-oxadiazole derivatives. Bioorg. Med. Chem.Lett. 2006, 16, 5036–5040. [Google Scholar]
  12. Sawant, R.; Lanke, P.; Jadhav, G.; Bhangale, L. QSAR analysis of structurally similar 1,3,4-oxadiazoles as enzyme tyrosinase inhibitors. Drug Invent. Today 2010, 2, 169–172. [Google Scholar]
  13. Sánchez, A.G.; Roldán, A.R. Dehydraion of 2-(D-arabino-tetrahyroxybutyl)furans. Carbohydr. Res. 1972, 22, 53–62. [Google Scholar]
  14. González, F.G. Reactions of monosaccharides with beta-ketonic esters and related substances. In Advances in Carbohydrate Chemistry; Wolfrom, L.M., Tipson, S.R., Eds.; Academic Press Inc.: New York, NY, USA, 1956; Volume 11, pp. 97–143. [Google Scholar]
  15. El-Sallam, M.A.; Hegazy, E.I.A. Studies on 3-epimeric 2-hexulose phenylosazones. Structure and anomeric configuration of the 3,6-anhydro-osazone derivatives obtained from D-arabino- and D-ribo-2-hexulose phenylosazone. Carbohydr. Res. 1981, 95, 177–188. [Google Scholar]
  16. El-Sallam, M.A.; Ibrahim, E.S.I.; El-Eter, K.A.A.; Cassady, J.M. Synthesis and anomeric configuration of 2-(erythrofuranosyl)benzimidazole C-nucleoside analogues. Carbohydr. Res. 1997, 298, 93–104. [Google Scholar] [CrossRef]
  17. Sable, H.Z.; Ritchey, W.M.; Nordlander, J.E. Studies on cyclic polyols part IV. Nuclear magnetic resonance spectra and configurational assignments of polyhydroxycyclopentanes. Carbohydr. Res. 1965, 1, 10–21. [Google Scholar] [CrossRef]
  18. MacCoss, M.; Robins, M.J.; Rayner, B.; Imbach, J.L. A new aspect of the use of 2',3'-O-isopropylidene ribonucleosides for investigation of anomeric configuration. Carbohydr. Res. 1977, 59, 575–579. [Google Scholar] [CrossRef]
  19. Maeba, I.; Iwata, K.; Usami, F.; Furukawa, H. C-Nucleosides 1. Synthesis of 3-(β-D-ribofuranosyl) pyridazines. J. Org. Chem. 1983, 48, 2998–3002. [Google Scholar]
  20. Hassan, S.Y.; Yaccout, G.A.; Abd El-Dayem, N.S.; El Sadek, M.M. Chemistry Department, Faculty of Science, Alexandria University, Alexandria, Egypt. Unpublished work, 2009.
  21. El Sadek, M.M.; Zagzoug, N.B.; El Soccary, N.N. Reactions of 2-methyl-5-(D-arabino-tetrahydroxybutyl)-3-furoylhydrazine. Carbohydr. Res. 1993, 250, 323–326. [Google Scholar] [CrossRef]
  22. Sánchez, A.G.; Roldán, A.R. Dehydration of 2-(D-arabino-tetrahydroxybutyl)furans. Carbohydr. Res. 1972, 22, 53–62. [Google Scholar] [CrossRef]
  23. Guthrie, R.D.; Honeyman, J. Periodate oxidation of methyl 4:6-O-benzylidene-a-D-glucoside. Chem. Ind. 1958, 29, 388–389. [Google Scholar]
  24. Alexandrou, N.E. Reassignment of structures of the dihydro-v-tetrazines. II: Mechanism of oxidation of diacylhydrazones. Tetrahedron 1966, 22, 1309–1316. [Google Scholar]
  25. El Khadem, H.; Shaban, M.A.E. Carbohydrate derivatives of 1-substituted 1,2,3-triazoles. J. Chem. Soc. C 1967, 519–520. [Google Scholar] [CrossRef]
  26. El-Khadem, H.; Shaban, M.A.E.; Nassr, M.A.M. Oxidation of mesoxalaldehyde bis- and tris-(benzoylhydrazones). J. Chem. Soc. C 1969, 1969, 1416–1418. [Google Scholar]
  27. El-Khadem, H.; El-Sadik, M.M.; Meshreki, M.H. Reactions of phenylglyoxal bisarylhydrazones. J. Chem. Soc. C 1968, 1968, 2097–2099. [Google Scholar]
  28. Ni, X.; Chan, D.; Chan, K.; McMain, S.; Kennedy, J.L. Serotonin genes and gene-gene interactions in borderline personality disorder in a matched case-control study. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33, 128–133. [Google Scholar] [CrossRef]
  29. Upadhyay, A.K.; Edmondson, D.E. Characterization of detergent purified recombinant rat liver monoamine oxidase B expressed in Pichia pastoris. Protein Expr. Purif. 2008, 59, 349–356. [Google Scholar] [CrossRef]
  30. Setini, A.; Pierucci, F.; Senatori, O.; Nicotra, A. Molecular characterization of monoamine oxidase in zebrafish (Danio rerio). Comp. Biochem. Physiol. 2005, 140, 153–161. [Google Scholar] [CrossRef]
  31. Kaneda, Y.; Fujii, A.; Nagamine, I. Platelet serotonin concentrations in medicated schizophrenic patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 2001, 25, 983–992. [Google Scholar] [CrossRef]
  32. Garpenstrand, H.; Longato-Stadler, E.; Klinteberg, B.A.; Grigorenko, E.; Damberg, M.; Oreland, L.; Hallman, J. Low platelet monoamine oxidase activity in Swedish imprisoned criminal offenders. Eur. Neuropsychopharmacol. 2002, 12, 135–140. [Google Scholar]
  33. Parsian, A.; Racette, B.; Zhang, Z.H.; Rundle, M.; Perlmutter, J.S. Association of variations in monoamine oxidases A and B with Parkinson’s disease subgroups. Genomics 2004, 83, 454–460. [Google Scholar] [CrossRef]
  34. Paris, J.; Zweig-Frank, H.; Ying Kin, N.M.K.N.; Schwartz, G.; Steiger, H.; Nair, N.P.V. Neurobiological correlates of diagnosis and underlying traits in patients with borderline personality disorder compared with normal controls. Psychiatry Res. 2004, 121, 239–252. [Google Scholar] [CrossRef]
  35. Vindis, C.; Séguélas, M.H.; Bianchi, P.; Parini, A.; Cambon, C. Monoamine oxidase B induces ERK-dependent cell mitogenesis by hydrogen peroxide generation. Biochem. Biophys. Res. Commun. 2000, 271, 181–185. [Google Scholar] [CrossRef]
  36. Carpéné, C.; Daviaud, D.; Boucher, J.; Bour, S.; Visentin, V.; Grès, S.; Duffaut, C.; Fontana, E.; Testar, X.; Saulnier-Blache, J.S.; et al. Short- and long-term insulin-like effects of monoamine oxidases and semicarbazide-sensitive amine oxidase substrates in cultured adipocytes. Metabolism 2006, 55, 1397–1405. [Google Scholar] [CrossRef]
  37. Rommelspacher, H.; Meier-Henco, M.; Smolka, M.; Kloft, C. The levels of norharman are high enough after smoking to affect monoamineoxidase B in platelets. Eur. J. Pharmachol. 2002, 441, 115–125. [Google Scholar] [CrossRef]
  38. Petzer, J.P.; Castagnoli, N., Jr; Schwarzschild, M.A.; Chen, J.F.; Schyf, C.J.V.D. Dual-target-directed drugs that block monoamine oxidase B and adenosine A2A receptors for Parkinson’s disease. Neurotherapeutics 2009, 6, 141–151. [Google Scholar]
  39. Rahman, M.A. Chalcone: A valuable insight into the recent advances and potential pharmacological activities. Chem. Sci. J. 2011. CSJ-29. [Google Scholar]
  40. Green, A.L.; El Hait, M.A.S. p-Methoxyamphetamine, a potent reversible inhibitor of type-A monoamine oxidase in vitro and in vivo. J. Pharm. Pharmacol. 1980, 32, 262–266. [Google Scholar]

Share and Cite

MDPI and ACS Style

El-Sadek, M.M.; Hassan, S.Y.; El-Dayem, N.S.A.; Yacout, G.A. 5-(5-Aryl-1,3,4-oxadiazole-2-carbonyl)furan-3-carboxylate and New Cyclic C-Glycoside Analogues from Carbohydrate Precursors with MAO-B, Antimicrobial and Antifungal Activities. Molecules 2012, 17, 7010-7027. https://doi.org/10.3390/molecules17067010

AMA Style

El-Sadek MM, Hassan SY, El-Dayem NSA, Yacout GA. 5-(5-Aryl-1,3,4-oxadiazole-2-carbonyl)furan-3-carboxylate and New Cyclic C-Glycoside Analogues from Carbohydrate Precursors with MAO-B, Antimicrobial and Antifungal Activities. Molecules. 2012; 17(6):7010-7027. https://doi.org/10.3390/molecules17067010

Chicago/Turabian Style

El-Sadek, Mohamed Mohamed, Seham Yassen Hassan, Nagwa Said Abd El-Dayem, and Galila Ahmed Yacout. 2012. "5-(5-Aryl-1,3,4-oxadiazole-2-carbonyl)furan-3-carboxylate and New Cyclic C-Glycoside Analogues from Carbohydrate Precursors with MAO-B, Antimicrobial and Antifungal Activities" Molecules 17, no. 6: 7010-7027. https://doi.org/10.3390/molecules17067010

APA Style

El-Sadek, M. M., Hassan, S. Y., El-Dayem, N. S. A., & Yacout, G. A. (2012). 5-(5-Aryl-1,3,4-oxadiazole-2-carbonyl)furan-3-carboxylate and New Cyclic C-Glycoside Analogues from Carbohydrate Precursors with MAO-B, Antimicrobial and Antifungal Activities. Molecules, 17(6), 7010-7027. https://doi.org/10.3390/molecules17067010

Article Metrics

Back to TopTop